Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Hassman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Diabetes Research and Clinical Practice|January 24, 2004
Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazoneLois Jovanovic, David R Hassman, Brent Gooch, et al.
American Heart Journal|December 18, 2002
Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trialW Virgil Brown, Harold E Bays, David R Hassman, et al.
Mayo Clinic Proceedings|May 12, 2007
Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trialWilliam Insull, Jalal K Ghali, David R Hassman, et al.
Diabetes Care|May 27, 2004
Repaglinide versus nateglinide monotherapy: a randomized, multicenter studyJulio Rosenstock, David R Hassman, Robert D Madder, et al.
The Diabetes Educator|April 21, 2004
Patient perception and use of an insulin injector/glucose monitor combined deviceBruce Bode, John Shelmet, Brent Gooch, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Diabetes Research and Clinical Practice|January 24, 2004
Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazoneLois Jovanovic, David R Hassman, Brent Gooch, et al.
American Heart Journal|December 18, 2002
Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trialW Virgil Brown, Harold E Bays, David R Hassman, et al.
Mayo Clinic Proceedings|May 12, 2007
Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trialWilliam Insull, Jalal K Ghali, David R Hassman, et al.
Diabetes Care|May 27, 2004
Repaglinide versus nateglinide monotherapy: a randomized, multicenter studyJulio Rosenstock, David R Hassman, Robert D Madder, et al.
The Diabetes Educator|April 21, 2004
Patient perception and use of an insulin injector/glucose monitor combined deviceBruce Bode, John Shelmet, Brent Gooch, et al.
Pageof 1